U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07811635) titled 'PRISM Trial: Partial Breast Versus Whole Breast Radiation in Early Breast Cancer' on Aug. 06.
Brief Summary: Breast-conserving surgery followed by radiotherapy is a standard treatment for women with early-stage breast cancer. Whole breast irradiation (WBI) is the current standard approach, but partial breast irradiation (PBI), which treats only the area surrounding the original tumor, may reduce radiation exposure to healthy tissues while maintaining similar treatment effectiveness.
The PRISM Trial is a prospective, multicenter, phase II randomized controlled trial that will compare ultra-hypofractionated PBI and WBI using the sam...